Αποτελέσματα Αναζήτησης
Mirena is indicated for the treatment of heavy menstrual bleeding for up to 5 years in women who choose to use intrauterine contraception as their method of contraception; replace after the end of the fifth year if continued treatment of heavy menstrual bleeding is needed.
Mirena is indicated for the treatment of heavy menstrual bleeding for up to 5 years in women who choose to use intrauterine contraception as their method of contraception; replace after the end of the fifth year if continued treatment of heavy menstrual bleeding is needed.
24 Νοε 2000 · It is also important to counsel women about how their bleeding pattern may change after insertion of MIRENA. The instructions for insertion should be followed carefully. The patient should be re-examined 4 to 12 weeks after insertion and once a year thereafter, or more frequently if clinically indicated.
MIRENA may be used with caution in women who have congenital heart disease or valvular heart . disease at risk of infective inflammation of the heart muscle. Antibiotic preventive medication should be administered to these patients when inserting or removing MIRENA.
30 Μαΐ 2014 · endometrial pathology (polyps or cancer) prior to the insertion of Mirena in women with persistent or uncharacteristic bleeding [see Warnings and Precautions (5.8)]. Follow the insertion instructions exactly as described to ensure proper placement and avoid premature release of Mirena from the inserter. Once released, Mirena cannot be re-loaded.
Step by Step Insertion & Removal Guide. for Bayer’s Intrauterine Devices: Kyleena®, Mirena®, and Skyla®. INDICATION FOR KYLEENA: Kyleena® (levonorgestrel-releasing intrauterine system) 19.5 mg is indicated for the prevention of pregnancy for up to 5 years. Replace the system after 5 years if continued use is desired.
Browse Mirena® (levonorgestrel-releasing intrauterine system) 52 mg IUD resources for you, your staff, & your patients. See full prescribing and safety info.
